Abstract
Capecitabine has been more recognized for its cardiotoxicity with an incidence that varies widely. It demonstrates its toxicity in the forms of acute coronary syndrome, arrhythmias and, to a lesser extent, cardiomyopathy. There are several proposed theories including coronary vasospasm, endothelial injury, and oxidative stress. We present a case of capecitabine-induced cardiomyopathy in a patient with pancreatic cancer and mild coronary artery disease, and shed light on other cardio-toxic agents, their proposed mechanism of cardiotoxicity, and on cardiomyopathy in general.
| Original language | American English |
|---|---|
| Journal | Internal Medicine |
| State | Published - Aug 1 2021 |
Keywords
- Capecitabine
- Humans
- Incidence
- Neoplasms
- Takotsubo Cardiomyopathy
Disciplines
- Cardiology
- Cardiovascular Diseases
- Internal Medicine
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS